
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17095261
[patent_doc_number] => 20210283052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => PH-DEPENDENT VAGINAL COMPOSITIONS AND METHODS OF TREATMENT OF VAGINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/222444
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222444 | PH-DEPENDENT VAGINAL COMPOSITIONS AND METHODS OF TREATMENT OF VAGINAL DISORDERS | Apr 4, 2021 | Abandoned |
Array
(
[id] => 17198582
[patent_doc_number] => 20210338676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => FATTY ACID SYNTHASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/221649
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221649
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221649 | Fatty acid synthase inhibitors | Apr 1, 2021 | Issued |
Array
(
[id] => 18716485
[patent_doc_number] => 11793806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Pyruvate kinase activators for use in therapy
[patent_app_type] => utility
[patent_app_number] => 17/221423
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 12716
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221423 | Pyruvate kinase activators for use in therapy | Apr 1, 2021 | Issued |
Array
(
[id] => 18893641
[patent_doc_number] => 20240009126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING MULTIPLE ORGAN DYSFUNCTION SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/934112
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934112
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934112 | Compositions and methods for treating or preventing multiple organ dysfunction syndrome | Apr 1, 2021 | Issued |
Array
(
[id] => 17124333
[patent_doc_number] => 20210299101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/301178
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301178 | SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION | Mar 28, 2021 | Abandoned |
Array
(
[id] => 17154787
[patent_doc_number] => 20210315838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/301188
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301188 | SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION | Mar 28, 2021 | Abandoned |
Array
(
[id] => 17124441
[patent_doc_number] => 20210299209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/301191
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301191
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301191 | SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION | Mar 28, 2021 | Abandoned |
Array
(
[id] => 18978784
[patent_doc_number] => 11903938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Methods of treating Fabry patients having renal impairment
[patent_app_type] => utility
[patent_app_number] => 17/213632
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 19819
[patent_no_of_claims] => 125
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213632
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/213632 | Methods of treating Fabry patients having renal impairment | Mar 25, 2021 | Issued |
Array
(
[id] => 17161703
[patent_doc_number] => 11147785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Modified free amino acid formulation and uses
[patent_app_type] => utility
[patent_app_number] => 17/209786
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2899
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209786 | Modified free amino acid formulation and uses | Mar 22, 2021 | Issued |
Array
(
[id] => 18322691
[patent_doc_number] => 20230120819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/906229
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906229
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906229 | METHODS AND COMPOSITIONS FOR TREATING ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS SYNDROME | Mar 18, 2021 | Pending |
Array
(
[id] => 17458688
[patent_doc_number] => 20220071992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/206241
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206241 | METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION | Mar 18, 2021 | Abandoned |
Array
(
[id] => 17095343
[patent_doc_number] => 20210283134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS OF TREATING CHOLANGIOCARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/204830
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204830 | Methods of treating cholangiocarcinoma | Mar 16, 2021 | Issued |
Array
(
[id] => 18491500
[patent_doc_number] => 11696905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Ready-to-use tranexamic acid intravenous solution
[patent_app_type] => utility
[patent_app_number] => 17/203215
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13595
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203215 | Ready-to-use tranexamic acid intravenous solution | Mar 15, 2021 | Issued |
Array
(
[id] => 17065725
[patent_doc_number] => 20210267940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS
[patent_app_type] => utility
[patent_app_number] => 17/200719
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200719 | Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters | Mar 11, 2021 | Issued |
Array
(
[id] => 16930762
[patent_doc_number] => 20210196651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/198965
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198965 | Use of cannabinoids in the treatment of epilepsy | Mar 10, 2021 | Issued |
Array
(
[id] => 18589162
[patent_doc_number] => 11738034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Triphenylphosphonium-derivative compounds for eradicating cancer stem cells
[patent_app_type] => utility
[patent_app_number] => 17/199087
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 5941
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199087 | Triphenylphosphonium-derivative compounds for eradicating cancer stem cells | Mar 10, 2021 | Issued |
Array
(
[id] => 17161726
[patent_doc_number] => 11147808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Method of decreasing the fluctuation index of dextromethorphan
[patent_app_type] => utility
[patent_app_number] => 17/194739
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 63686
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194739 | Method of decreasing the fluctuation index of dextromethorphan | Mar 7, 2021 | Issued |
Array
(
[id] => 18799984
[patent_doc_number] => 11833127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Compositions and methods for the treatment of fat infiltration in muscle
[patent_app_type] => utility
[patent_app_number] => 17/189884
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14467
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189884 | Compositions and methods for the treatment of fat infiltration in muscle | Mar 1, 2021 | Issued |
Array
(
[id] => 17109990
[patent_doc_number] => 20210290587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => TREATING IRON DEFICIENCY WITH FERRIC CARBOXYMALTOSE
[patent_app_type] => utility
[patent_app_number] => 17/187992
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187992 | Treating iron deficiency with ferric carboxymaltose | Feb 28, 2021 | Issued |
Array
(
[id] => 17065745
[patent_doc_number] => 20210267960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHODS OF TREATMENT OF INFLAMMATORY CYTOKINE-RELATED ARTHRITIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/185034
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185034 | METHODS OF TREATMENT OF INFLAMMATORY CYTOKINE-RELATED ARTHRITIC DISORDERS | Feb 24, 2021 | Abandoned |